Larimar Therapeutics Inc (LRMR)
R&D Expense Growth
11.86%
Quarterly · Period ending:
LRMR R&D Expense Growth
Latest reported11.86%period ending
Latest reported11.86%period ending
LRMR Quarterly R&D Growth (QoQ) (0.00% → 11.86%)
Latest values, visible window
High-resolution chart · PNG
LRMR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 11.8613% | |
| -57.8411% | |
| 32.1426% | |
| 92.2758% | |
| -11.9916% | |
| -0.6956% | |
| 92.0971% | |
| -29.2806% | |
| 53.0601% | |
| 21.6902% | |
| 60.4708% | |
| 12.0851% | |
| 28.7812% | |
| -36.7969% | |
| 29.3085% | |
| -1.0985% | |
| -2.7902% | |
| -7.7241% | |
| -55.1468% | |
| 54.12% | |
| 1.4263% | |
| -15.1315% | |
| 52.8256% | |
| -22.3195% | |
| 77.891% | |
| -7.3807% | |
| -32.711% | |
| 156.8414% | |
| 73,988.1099% | |
| -99.9631% | |
| -3.153% | |
| -3.1043% | |
| -1.8017% | |
| 13.9492% | |
| 12.2185% | |
| -7.6463% | |
| 8.794% | |
| 33.0172% | |
| -27.2573% | |
| -1.594% | |
| -18.6765% | |
| -29.4194% | |
| 24.9453% | |
| 13.1327% | |
| 22.6236% | |
| 0% | |
| 0% | |
| 157.2098% | |
| 0% |